|
CSRP2BP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.77644573998259E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76360037684731E-11 |
| Normal-vs-Stage2 |
5.560500E-03 |
| Normal-vs-Stage3 |
4.235500E-03 |
| Normal-vs-Stage4 |
1.616360E-02 |
| Stage1-vs-Stage2 |
9.435000E-01 |
| Stage1-vs-Stage3 |
8.635400E-01 |
| Stage1-vs-Stage4 |
6.474000E-01 |
| Stage2-vs-Stage3 |
8.675400E-01 |
| Stage2-vs-Stage4 |
7.802000E-01 |
| Stage3-vs-Stage4 |
6.809600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60329971521378E-10 |
| Normal-vs-AfricanAmerican |
3.8032998972426E-10 |
| Normal-vs-Asian |
3.63100000000394E-05 |
| Caucasian-vs-AfricanAmerican |
2.694800E-01 |
| Caucasian-vs-Asian |
6.292000E-01 |
| AfricanAmerican-vs-Asian |
8.346200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.19024798298051E-12 |
| Normal-vs-Female |
1.6291499999932E-05 |
| Male-vs-Female |
1.161560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.93670000003809E-06 |
| Normal-vs-Extreme_Weight |
4.63390437133171E-11 |
| Normal-vs-Obese |
2.49249999999535E-05 |
| Normal-vs-Extreme_Obese |
1.338120E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.604600E-01 |
| Normal_Weight-vs-Obese |
4.462600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.325800E-01 |
| Extreme_Weight-vs-Obese |
1.632030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.960000E-01 |
| Obese-vs-Extreme_Obese |
3.683400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.365830E-02 |
| Normal-vs-Age(41-60Yrs) |
3.38490000029168E-07 |
| Normal-vs-Age(61-80Yrs) |
1.46505030329536E-12 |
| Normal-vs-Age(81-100Yrs) |
2.12929999999778E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.674600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.332800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.794000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.563900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.092100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.502300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.38639999480716E-09 |
| Normal-VS-Type2 PRCC |
3.6597003205685E-10 |
| Normal-VS-KIRP CIMP |
1.9642999449232E-09 |
| Normal-VS-Unclassified PRCC |
1.327850E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.886100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.802200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.122400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.031400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.109900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.680440E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4290999994504E-07 |
| Normal-vs-N1 |
7.037300E-03 |
| Normal-vs-N2 |
8.87689999951036E-07 |
| N0-vs-N1 |
3.268600E-01 |
| N0-vs-N2 |
5.103200E-01 |
| N1-vs-N2 |
2.843600E-01 |
|
|
